Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Genitourinary 1Gastrointestinal 1Dermatologic 1CNS 1

Conditions

Neuroblastoma 11Sarcoma 4Rhabdoid Tumor 4Medulloblastoma 4Central Nervous System Neoplasms 4Hepatoblastoma 3Brain Neoplasms 3Wilms Tumor 2Sarcoma, Ewing 2Rhabdomyosarcoma 2Retinoblastoma 2Neoplasms, Germ Cell and Embryonal 2Carcinoma, Renal Cell 2Sarcoma, Clear Cell 1Pyloric Stenosis, Hypertrophic 1Pinealoma 1Osteosarcoma 1Optic Nerve Glioma 1Neurofibrosarcoma 1Neuroectodermal Tumors, Primitive, Peripheral 1Neuroectodermal Tumors, Primitive 1Neoplasms 1Melanoma 1Liver Neoplasms 1Kidney Neoplasms 1Ganglioneuroblastoma 1Familial ependymoma 1Desmoplastic Small Round Cell Tumor 1Carcinoma, Hepatocellular 1Carcinoma 1

Interventions

Cyclophosphamide 2pembrolizumab 1molibresib 1fludarabine phosphate 1fludarabine 1etoposide phosphate 1Temozolomide 1Sirolimus 1Pemetrexed 1Oncolytic Virotherapy 1Mesna 1Etoposide 1Craniotomy 1Celecoxib 1Carboplatin 1ADI PEG20 13-(5-amino-2-methyl-4-oxoquinazolin-3(4H)-yl)piperidine-2,6-dione 11-ethyl-7-(2-methyl-6-(1H-1,2,4-triazol-3-yl)pyridin-3-yl)-3,4-dihydropyrazino(2,3-b)pyrazin-2(1H)-one 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma × Mesna × CNS × Clear all
NCT04897321 2026-05-19

B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR)

St. Jude Children's Research Hospital

Phase 1 Recruiting
48 enrolled
CNSDermatologicGastrointestinalGenitourinarySarcoma

Adrenal Cortex Neoplasms, Carcinoma, Melanoma, Neoplasms, Germ Cell and Embryonal, Wilms Tumor, Neuroblastoma, Rhabdomyosarcoma, Sarcoma, Sarcoma, Ewing, Osteosarcoma, Hepatoblastoma, Sarcoma, Clear Cell, Neurofibrosarcoma, Rhabdoid Tumor, Desmoplastic Small Round Cell Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡